July 27, 2024
Healthcare

Increasing healthcare expenditure to stimulate growth of the global generic drugs market

Karan Mukherjeeby Karan Mukherjee

 

Generic drugs contain the same active ingredients and are equivalent to their branded counterparts in dosage form, strength, route of administration, quality and efficacy. They are increasingly used as an alternative to treat various chronic and acute conditions in a cost effective manner. The market comprises products like tablets, capsules, injectables and others used for therapeutic areas including cardiovascular, anti-infective, neurological disorders and diabetes.

The Generic Drugs Market is estimated to be valued at US$ 439.37 Bn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Increasing healthcare costs have prompted government bodies across countries to support and promote generic versions of drugs. This has led to significant price reductions of off-patent drugs. Further, Patent expiration of many blockbuster drugs has opened opportunities for generic manufacturers to introduce biosimilar versions. For instance, the patent expiry of biologics like Humira, Revlimid and others between 2023-2025 is anticipated to boost generic drug production. Additionally, high incidence and economic burden of chronic diseases like cancer, diabetes etc. has augmented the demand for low-cost generic medications for long-term treatment and management. Various initiatives aimed at enhancing access to affordable medicines complement market growth. However, complexities involved in the development of generic biosimilars and rising price pressure on manufacturers may impede the marketexpansion to some extent.

Segment Analysis
The global generic drugs market is segmented on the basis of dosage form into oral, topical, injectables and others. Among these, the oral segment dominates the market and accounts for the largest revenue share. This is because oral drugs are convenient to administer and provide better patient compliance as compared to other dosage forms such as injectables. Oral generic drugs also have lower production costs as compared to other dosage forms.

PEST Analysis
Political: The governments across various countries are focusing on reducing healthcare costs by promoting use of generic drugs. They offer cost savings of 40-70% over branded drugs. This is positively impacting the market growth.
Economic: The global generic drugs market is expected to grow at a significant pace due to rising healthcare expenditure worldwide coupled with increasing prevalence of chronic diseases. Growing geriatric population which is more prone to illnesses also contributes to market growth.
Social: Changing lifestyles and dietary patterns have led to a rise in lifestyle diseases. This has increased the demand for pharmaceutical drugs for treatment as well as management of diseases. Increasing awareness about cost-effective generic drugs is also fueling the market expansion.
Technological: Continuous R&D efforts and advanced manufacturing techniques adopted by generic drug players have helped address issues related to bioequivalence and quality. This has improved product differentiation and competitive advantage.

Key Takeaways
– The global generic drugs market size was valued at USD 439.37 billion in 2023 and is expected to reach over USD 658 billion by 2030, exhibiting a CAGR of 5.4% during the forecast period. Growth of the market can be attributed to rising need for cost-effective treatment options and increasing prevalence of chronic diseases.

– Regionally, North America dominates the global generic drugs market and is anticipated to continue leading over the projected timeframe. This is owing to rising healthcare costs in the region prompting greater adoption of low-cost generic medicines. The presence of key players as well as advancement in manufacturing facilities also support market growth in North America.

– Key players operating in the generic drugs market are Mylan N.V., Novartis International AG, Pfizer, Inc., Allergan Plc, Sun Pharmaceuticals, Fresenius Kabi, Sanofi, Endo International, Lupin Ltd., Abbott Healthcare, AstraZeneca Plc, and Novo Nordisk. Strategic collaborations, new product launches and strengthening of manufacturing infrastructure have been key growth strategies adopted by these players.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research
  2. We have leveraged AI tools to mine information and compile it
Karan Mukherjee

Karan Mukherjee

View all posts by Karan Mukherjee →

You might also like

Brazil Injectable Drugs Market for Hospitals & Ambulatory Settings Industry Market

Brazil Injectable Drugs Market For Hospitals & Ambulatory Settings Industry Market Is Expected To Be Flourished By Increasing Government Initiatives To Promote Tourism IndustryThe Saudi Arabia MICE market involves organizing and hosting different business related events such as meetings, conferences, trade shows, exhibitions, and other corporate events. It plays a crucial role in the business world by enabling networking opportunities, education and training opportunities. The MICE industry attracts potential investors, businesses, and tourists by organizing informative exhibitions and trade shows. The government of Saudi Arabia has taken several initiatives to diversify its economy and reduce dependency on oil exports. It aims to promote tourism by developing world-class infrastructure and hosting global events. Mega projects such as NEOM, Red Sea Project, and Qiddiya Entertainment City will attract global MICE events. The global Saudi Arabia MICE Market is estimated to be valued at US$ 7.2 billion in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023-2033, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: Increasing Government Initiatives to Promote Tourism Industry The government has announced initiatives such as Vision 2030 to promote tourism and culture. It aims to increase tourism contribution to GDP from 3% to 10% by 2030. Projects such as Qiddiya entertainment city worth US$ 50 billion will feature theme parks, motor sport facilities and hotel accommodation that can host MICE events. This will boost the country’s MICE market. Rising Demand from Growing Corporate Sector The corporate sector in Saudi Arabia is rapidly expanding due to industrialization and privatization reforms. Many national and multinational companies are setting up offices and production facilities in the country. This is driving the demand for MICE activities and events from the corporate sector. Organization of conferences, product launches, employee trainings and other corporate events help businesses to promote brand, business development and networking. Segment Analysis The Saudi Arabia MICE market is dominated by corporate meetings and events segment. Majority of MICE industry events in Saudi Arabia are corporate meetings and training events held by different private and public organizations operating in the kingdom. The corporate meetings and events sub-segment accounts for over 60% of the total MICE market revenue owing to large scale business operations and increasing focus on training and development programs by organizations across industries. PEST Analysis Political: The government of Saudi Arabia is promoting tourism and diversifying economy away from oil through various initiatives like Vision 2030. This is positively impacting the growth of MICE industry in the country. Economic: Strong GDP growth, young population and growing workforce are driving demand for corporate events, conferences and exhibitions. Oil wealth is also enabling large investments in tourism infrastructure development. Social: Changing social norms, growing awareness about lifestyle and work-related events are encouraging participation in MICE activities. Influx of expat workers is further boosting industry volumes. Technological: Adoption of digital tools for event planning, management and marketing as well as availability of high-speed internet and wireless connectivity across major cities is enhancing consumer experience. Key Takeaways The Brazil Injectable Drugs Market for Hospitals & Ambulatory Settings is expected to witness high growth driven by objectives of Vision 2030 plan to diversify economy and promote tourism. The regional analysis indicates that Riyadh region accounts for around 40% of total MICE activities led by availability of most prominent venues like Riyadh International Convention and Exhibition Center. Jeddah and Eastern region follow Riyadh and collectively account for over 35% share backed by significant corporate base and growing attraction as tourist destinations. Key players operating in the Saudi Arabia MICE market are Mosaic Group, Alkhair International, Motivate Middle East and Image Nation. Mosaic Group is a prominent player widening their portfolio of world-class venues. Hyatt recently acquired the hospitality business of Atrium and aims to leverage their portfolio of leading hotels to tap opportunities arising from Vision 2030 goals.

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

Contract Pharmaceutical Manufacturing Market: Growing at a CAGR of 9.3% during 2022-2030, it is estimated to reach a value of US$ 178.94 billion by 2022

Huntington's Disease Treatment Market

Huntington’s Disease Treatment Market: Rising Prevalence of Huntington’s Disease to Drive Market Growth